Bromelain proteases suppress growth, invasion and lung metastasis of B16F10 mouse melanoma cells

International Journal of Oncology

Volumn 11, Issue 2, 1997, Pages 243-248

  Grabowska, Edyta ^a   Eckert, Klaus ^a   Fichtner, Iduna ^b   Schulze Forster, Kai ^a   Rainer Maurer, H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

B16F10 melanoma cells; Bromelain proteases; CD44; Cell proliferation; In vitro; In vivo; Invasion; Lung metastasis

Indexed keywords

BROMELAIN; PROTEINASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; DRUG EFFECT; ENZYME ISOLATION; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030797631     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.2.243     Document Type: Article

References (31)

1. Harrach T, Eckert K, Schulze-Forster K, Nuck R, Grunow D and Maurer HR: Isolation and partial characterisation of basic proteinases from stem bromelain. J Protein Chem 14: 41-52, 1995.
2. Harrach T, Eckert K, Maurer HR, Machleidt I, Machleidt W and Nuck R: Isolation and characterisation of two forms of an acidic bromelain stem proteinase. J Protein Chem (In press).
3. Taussig SJ and Batkin S: Bromelain, the enzyme complex of pineapple (ananas coinosus) and its clinical application. An update. J Ethnopharmacol 22: 191-203, 1988.
4. Batkin S, Taussig SJ and Szekerczes J: Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity. J Cancer Res Clin Oncol 114: 507-508, 1988.
5. Taussig SJ, Szekerczes J and Batkin S: Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosits). Planta Med 6: 538-539, 1985.
6. Maurer HR, Hozumi M, Honma Y and Okabe-Kado J: Bromelain induces the differentiation of leukemic cells in vitro: an explanation for its cytostatic effects? Planta Med 54: 377-381, 1988.
7. Garbin F, Harrach T, Eckert K and Maurer HR: Bromelain proteinase F9 augments human lymphocyte-mediated growth inhibition of various tumor cells in vitro. Int J Oncol 5: 197-203, 1994.
8. Besser L and Rehberger A: Induction of tumor necrosis factor in human peripheral blood mononuclear cells by proteolytic enzymes. Oncology 47: 475-477, 1990.
9. Desser L, Rehberger A, Kokron E and Pankovits W: Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparation. Oncology 50: 403-407,1993.
10. Desser L, Rehberger A and Pankovits W: Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother 9: 253-261, 1994.
11. Hale LP and Haynes BF: Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8 and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 149: 3809-3816, 1992.
12. Munzig E, Eckert K, Harrach T, Graf H and Maurer HR: Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett 351: 215-218, 1994.
13. Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P and Ponta H: A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53: 1516-1521, 1993.
14. Gotley DC, Fasvcett J, Walsh MD, Reeder JA, Simmons DL and Antalis TM: Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 74: 342-351, 1996.
15. Birch M, Mitchell S and Hart IR: Isolation and characterisation of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51: 6660-6667, 1991.
16. Ishiguro T, Nakajima M, Naito M, Muto T and Tsuruo T: Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res 56: 875-879, 1996.
17. Batkin S, Taussig SJ and Szekereczes J: Modulation of pulmonary metastasis (Lewis lung carcinoma) by bromelain, an extract of the pineapple stem (ananas comosus). Cancer Invest 6: 241-242, 1988.
18. Ota T, Matsui T, Kohno H, Maedo M, Tamino M and Odashima S: CD44 participates in tumor cell adhesion to endothelial cells in the experimental metastatic process in B16BL6 melanoma cells. Anticancer Res 15: 1215-1220, 1995.
19. Qian F, Bajkowski AS, Steiner DF, Chan SJ and Frankfater A: Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues. Cancer Res 49: 4870-4875, 1989.
20. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
21. Huijzer JC, Uhlenkott CE and Meadows GG: Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: lack of association with in vitro invasion. Int J Cancer 63: 92-99, 1995.
22. Wojtowicz-Praga S, Verma UM, Wakefield L, Esteban JM, Hartmann D and Mazumder A: Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor β antibody and interleukin-2. J Immunol 19: 169-175, 1996.
23. Ota T, Fujikawa-Yamamoto K, Zong Z, Yamazaki M, Odashima S, Kitagawa I, Abe H and Arichi S: Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 47: 3863-3867, 1987.
24. Im S-Y, Ko H-M, Ko Y-S, Kim J-W, Lee H-K, Ha T-Y, Lee HB, Oh S-J, Bai S, Chung K-C, Lee Y-B, Kang H-S and Chun S-B: Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 56: 2662-2665, 1996.
25. Gohla A, Eckert K and Maurer HR: A rapid and sensitive fluorometric screening assay using YO-PRO-I to quantify tumour cell invasion through matrigel. Clin Exp Metastasis 14: 451-458, 1996.
26. Ritonja A, Rowan AD, Buttle DJ, Rawlings DJ, Turk V and Barret AJ: Stem bromelain: amino acid sequence and implications for weak binding of cystatin. FEBS Lett 247: 419-424, 1989.
27. Harrach T, Gebauer F, Eckert K, Kunze R and Maurer HR: Bromelain proteinases modulate the CD44 expression on human Molt 4/8 leukemia and SK-Mel 28 melanoma cells in vitro. Int J Oncol 5: 485-488, 1994.
28. Behrendt N, Ronne E and Dano K: The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. J Biol Chem 376: 269-279, 1995.
29. Simon N, Noel A and Foidart J: Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells. Invasion Metastasis 12: 156-167, 1992.
30. Evans CW: The metastatic cell. In: Behaviour and Biochemistry. Chapman and Hall, London, pp 170-189, pp398-408, 1991.
31. Herrlich PH, Zöller M, Pals ST and Ponta H: CD44 splice variants: metastases meet lymphocytes. Immunol Today 14: 395-399, 1993.